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network analysis of canine brain 
morphometry links tumour risk 
to oestrogen deficiency and 
accelerated brain ageing
nina M. Rzechorzek  1,2,3, Olivia M. Saunders1, Lucy V. Hiscox4,5, Tobias Schwarz1, 
Katia Marioni-Henry1, David J. Argyle1, Jeffrey J. Schoenebeck  1 & tom c. freeman1
Structural ‘brain age’ is a valuable but complex biomarker for several brain disorders. The dog is an 
unrivalled comparator for neurological disease modeling, however canine brain morphometric diversity 
creates computational and statistical challenges. Using a data-driven approach, we explored complex 
interactions between patient metadata, brain morphometry, and neurological disease. Twenty-four 
morphometric parameters measured from 286 canine brain magnetic resonance imaging scans were 
combined with clinical parameters to generate 9,438 data points. Network analysis was used to cluster 
patients according to their brain morphometry profiles. An ‘aged-brain’ profile, defined by a small brain 
width and volume combined with ventriculomegaly, was revealed in the Boxer breed. Key features of 
this profile were paralleled in neutered female dogs which, relative to un-neutered females, had an 11-
fold greater risk of developing brain tumours. Boxer dog and geriatric dog groups were both enriched 
for brain tumour diagnoses, despite a lack of geriatric Boxers within the cohort. Our findings suggest 
that advanced brain ageing enhances brain tumour risk in dogs and may be influenced by oestrogen 
deficiency—a risk factor for dementia and brain tumours in humans. Morphometric features of brain 
ageing in dogs, like humans, might better predict neurological disease risk than patient chronological age.
The global burden of neurological disease has dramatically increased in the last 25 years, largely due to an ageing 
human population—a trend mirrored in companion animals1,2. Much overlap exists between humans and domes-
tic dogs with respect to age-linked vascular, degenerative, and neoplastic brain disorders. Shared environmental 
influences between these species, as well as the shorter lifespan and refined genetic architecture of pedigree dogs, 
has driven canines to the leading edge of comparative neurological disease modeling3–6.
Brain ageing varies among humans, and biological (physiological) ‘brain age’ better predicts disease risk than 
chronological age7–13. These divergent ageing trajectories might be accentuated in the domestic dog, where selec-
tive breeding has produced extreme phenotypic diversity among pedigrees, and where breed plays a role in lon-
gevity and the onset of some age-related brain pathologies14–18. Emerging evidence points to an increased risk of 
disease and mortality in humans with structurally ‘older’-appearing brains—dementia, epilepsy, and schizophre-
nia have all been associated with this enhanced ‘brain age’8–10,12,13,19–22. Robust biomarkers of brain ageing are 
therefore of urgent clinical interest to identify individuals that deviate from a healthy ageing trajectory, enabling 
targeted early intervention8–10.
Certain brain morphometric parameters are predicted to change with neural decline8,9,16,18,23–41. However, 
age-related structural changes are subtle, non-linear, and non-uniform in their distribution8,10,42,43. Whilst a single 
measure is clinically convenient, it is unlikely to capture a phenotype for the complex biological process of age-
ing8–10. Machine learning techniques that estimate ‘brain age’ from human magnetic resonance imaging (MRI) 
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data rely on the fact that morphometric correlates of brain ageing vary little between healthy individuals8. This 
cannot be presumed in the dog, where breed morphometric variations present computational and statistical chal-
lenges5,14,44,45. Isolating allometric (size-dependent) and non-allometric shape variation is problematic46,47, and 
whilst automated MRI atlas-based protocols have emerged to assess canine brain morphometry44,45, their accu-
racy remains questionable for dogs with structural brain disease and different craniofacial morphologies5,29,44. 
These morphologies—brachycephalic, mesocephalic, and dolichocephalic (‘short-headed, medium-headed, and 
long-headed’, respectively)—can impact as much on brain shape, as they do on external features of the head14,44.
Recent studies have addressed the phenotypic diversity of the domestic dog15,44,45,48–53, but the morphomet-
ric diversity of the canine brain in a clinical context remains unexplored. Clinical datasets offer several advan-
tages, not least that the natural progression of disease can be observed on a background of both individual- and 
breed-based heterogeneity. An obvious challenge in exploiting such data is its complexity. To address this issue, 
we have employed correlation-based network analysis, an unbiased, data-driven method used originally for anal-
ysis of transcriptomics data54–56, and more recently to explore patient parameters associated with complex syn-
dromes57. A key attraction of network analysis is that it incorporates interactions within and between traits—as 
shown for behavioural phenotypes in dogs58. Moreover, network analysis can test previous assumptions made 
about disease mechanisms and the clinical significance of patient-derived observations57,59.
In this study, we have applied network correlation analysis to a complex canine neurological dataset to explore 
how MRI-based brain morphometry profiles vary according to patient demographics and diagnosis. Our objec-
tive was to test statistically for co-enrichment between patient factors, clinical data, and brain morphometric 
features to extract novel insights into neurological disease risk.
Methods
experimental design. The study plan was to conduct a large-scale, unbiased, hypothesis-generating analysis 
of complex patient data to identify factors that best predict neurological disease risk in dogs. The Royal (Dick) 
School of Veterinary Studies Hospital for Small Animals data management system was screened for canine brain 
MRI scans performed between July 2009 and March 2017. The start date was dictated by MRI availability, and 
the end point when a minimum of 300 brain scans had been scheduled. Inclusion criteria were MRI of the whole 
brain, with at least one transverse and one sagittal sequence (T1- or T2-weighted; T1w or T2w), and accessi-
ble clinical history. Patients with any trauma or procedure that would alter skull or brain morphometry were 
excluded. MRI scans were anonymized prior to blinded, quantitative data collection by one of two independent 
observers (observer A, O.M.S. and observer B, N.M.R.) using the same measurement protocol. Analysis of 47 
prospective scans (that met inclusion criteria) were used only to assist with craniofacial category assignment by 
craniofacial ratio (CFR), assessed by observer B.
Animals and ethics statement. MRI data were acquired from canine patients as part of routine diag-
nostic work-up. All patients had been referred to the Hospital and were assessed under the supervision of 
Board-certified specialists in Small Animal Internal Medicine and/or Neurology. Dogs were anaesthetized and 
scanned under the supervision of Board-certified specialists in Anaesthesia and Diagnostic Imaging, respec-
tively. Written informed consent of each dog owner was obtained for all diagnostic procedures and for the use of 
anonymized clinical and imaging data for research purposes.
Data acquisition. Categories of patient data used for this study are detailed in Supplementary Figs S1–S3. 
Body weight (kg) was extracted from the anaesthetic record on the day of MRI acquisition. Age was calculated 
using the date of birth and date of MRI acquisition. Meta-data (sex, breed, category of neurological diagnosis) 
were extracted using the clinical history, MRI report, clinical pathology reports, final neurologist report, and 
(where available) histopathology reports. ‘Breed group’ categories were assigned according to the UK Kennel 
Club registration system (http://www.thekennelclub.org.uk); mixed breed dogs, and those without official breed 
recognition were either designated a ‘Crossbreed’ grouping or grouped according to the main contributing breed 
(e.g. Patterdale Terrier = Terrier; Collie X = Pastoral; Beagle X, Whippet X = Hound). Patients were assigned to 
one of nine diagnostic categories (Supplementary Fig. S1). Anomalous conditions included Chiari-like malforma-
tion, syringomyelia, and hydrocephalus; inflammatory conditions were immune-mediated or infectious. The few 
dogs with degenerative myelopathy and normal brain MRIs were assigned a degenerative diagnosis. A ‘normal’ 
diagnostic category was assigned only in dogs with structurally normal brains where no neurological diagnosis 
was made (in these cases, brain MRI was used to rule out a frontal lobe lesion as an explanation for new-onset 
behavioural changes, where all other clinical tests had failed to reach a diagnosis). Brain morphometric fea-
tures were measured using OsiriX Medical Imaging Software, and included previously published parameters and 
recognized normalization factors (Supplementary Fig. S4). CFRs were derived using a modified version of the 
method described by Packer et al.60 in which muzzle length (non-linear distance from dorsal tip of nasal planum 
to the stop in mm) is divided by cranial length (non-linear distance from occipital protuberance to the stop in 
mm). Measurements and precise locations of the nasal planum, stop, and occipital protuberance were determined 
on mid-sagittal T2w images using the ‘open polygon’ tool of OsiriX and excluded obvious skin folds. Craniofacial 
categories were assigned to each patient based on (i) the CFR where available; i.e. where the dorsal tip of the nasal 
planum was included in the imaging field, (ii) the average CFR recorded for that patient’s breed within the cohort 
(for purebred dogs, and if there were more than two representatives of the breed with measurable CFRs) and/
or (iii) the cut-offs for craniofacial category assignment within our cohort (brachycephaly was defined as a CFR 
of ≤0.52, mesocephaly as >0.52 to <0.67, and dolichocephaly as ≥0.67). Overall, 139 scans were evaluated by 
observer A and 172 scans by observer B, with an overlap of 25 scans to evaluate reproducibility of the measure-
ment protocol. Measurements between observers were highly reproducible (variance <10%) for eight parameters; 
for the remainder, scans measured by observer A were re-measured blind by the more experienced observer B 
3Scientific RepoRtS |         (2019) 9:12506  | https://doi.org/10.1038/s41598-019-48446-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
(a board-eligible veterinary neurologist), before processing of the dataset for network analysis (Supplementary 
Fig. S4e). For scans evaluated by both observers, only data extracted by observer B were used for subsequent 
analysis.
Data processing. Raw (measured) data were processed prior to further analysis; brain length, cerebellar vol-
ume61, cerebellar diameter, interthalamic adhesion height, corpus callosum thickness, and ventricular parameters 
were normalized to total brain volume (which included ventricular volume)62. Cranial length, brain width, total 
brain volume, and sulcus depth were normalized to body weight to control for allometric scaling62. Cerebellar 
compression length, cerebellar compression index and obex position were normalized to head angle to con-
trol for patient positioning. Corpus callosum angle was not normalized. Normalized total brain volumes were 
retained within the dataset for network analysis but head angle was excluded. Measured ventricle height created 
a markedly skewed data set due to the recorded ‘zero’ value in most patients. These measurements were there-
fore categorized to indicate visual integrity of the septum pellucidum: 0 mm = ‘intact’, >0 mm < 3 mm = ‘minor’ 
loss, >3 mm < 6 mm = ‘moderate’ loss, >6 mm < 10 mm = ‘severe’ loss, >10 mm = ‘absent’. ‘Septal integrity’ 
thus became an additional meta-data parameter. Age at MRI was categorized as follows: >0 < 2 y = ‘Immature’, 
≥2 < 4 y = ‘Young adult’, ≥4 < 8 y = ‘Middle-aged’, ≥8 < 10 y = ‘Mature’, ≥10 y = ‘Geriatric’. Magnitude of variance 
differed greatly between morphometric measurements, with the potential to disproportionately bias clustering of 
dogs according to the impact of one or a few parameters. To ensure fair representation of all parameters within 
the correlation analysis, all numerical data were median-centered for each parameter.
network analysis. Normalized, scaled and categorized data were imported into Graphia Professional 
(Kajeka Ltd., Edinburgh UK), a network analysis software package that calculates data matrices, supports graph-
ical clustering, performs enrichment analyses and identifies patterns in large, complex datasets. The software 
was originally developed for the analysis of gene expression data, in which the correlation coefficient serves as a 
measure of co-expression between gene profiles and is used to define edges in a correlation network54. For this 
study, a Pearson correlation was chosen to measure similarity between individual MRI scans based on normalized 
global brain morphometry measurements. The network graph created from the data was based on a user-defined 
correlation threshold of r = 0.7. This threshold was chosen to incorporate the maximum number of nodes (patient 
scans) with a minimum number of edges (correlations between patient scans). The measurements of thirteen 
animals in the cohort shared no correlation with other animals above this threshold and were absent from the 
graph. Network topology was determined by the number of correlations > r = 0.7 between all scans. The Markov 
clustering (MCL) algorithm57 was used to subdivide the graph into discrete clusters of canine MRI scans sharing 
similar brain morphometric features. Granularity of the clustering (cluster size) is determined by the inflation 
value (MCLi). For this study, MCLi was set at 2.2 (smallest cluster size of three nodes). A detailed description and 
validation of the MCL algorithm can be found elsewhere (http://micans.org/mcl)63.
enrichment and statistical analysis. Graphia Professional’s enrichment analysis uses Fisher’s exact test 
to determine the probability of a cluster’s composition occurring purely by chance, and offers tools to statistically 
confirm enrichment of a particular class. Since the canine brain data contained several classes for each MRI scan, 
Fisher’s exact was used to test each cluster for a disproportionately high representation of each class descriptor. 
Enrichment outputs include a heatmap and table providing the observed and expected number of members of 
each class descriptor within each cluster. The corresponding adjusted Fisher’s P-value represents how statistically 
unlikely it is for a class descriptor to occur within a cluster; the lower this value, the more significant the result, 
and the more brightly it is displayed on the heatmap. All other analyses were conducted in GraphPad Prism 7.0. 
For comparisons between three or more groups of data, one-way analysis of variance (ANOVA; with Tukey’s 
multiplicity correction) or Kruskal-Wallis (with Dunn’s multiplicity correction) tests were applied as appropriate, 
based on data distributions. For comparisons between two data groups, unpaired two-tailed Mann-Whitney, or 
unpaired two-tailed t-tests (with Welch’s correction if indicated by F-test) were applied. Linear regressions tested 
for significance between lines of best fit, and Fisher’s exact test was used to assess odds ratios.
Results
complexity within a canine referral cohort. A total of 9,438 morphometric and clinical data points were 
extracted from 286 MRI scans conducted on 281 individual dogs (Figs 1a, S1). These included 61 UK Kennel Club 
breeds and all seven recognized Kennel Club breed groups (Supplementary Fig. S2, Supplementary Data File S1). 
The most common breeds in the cohort were Labrador Retriever (12.9%), Cavalier King Charles Spaniel (CKCS; 
8.7%), and Boxer (6.3%); 52.7% of scans derived from male dogs and 65.8% of patients were neutered. Median 
age at MRI was 6.8 y (range 0.2–17.4 y) and median body weight was 18.1 kg (range 1.2–97.0 kg). The distribution 
of body weights and ages according to breed grouping highlighted the diversity within our cohort (Figs 1b, S3). 
Measurements to determine CFRs60 were possible in 117 retrospective scans, and in 17 of 47 prospective scans 
used to support craniofacial category assignment (Figs 1c, S2b, S4, Supplementary Data File S2). Based on defined 
cut-offs, 35.7% of MRI scans used for network analysis derived from brachycephalic, 50.7% from mesocephalic, 
and 13.6% from dolichocephalic dogs. Brachycephalic dogs had shorter brains relative to their cranial length and 
were predominantly found within Toy, Utility and Working groups (Figs 1d–f, S3d). Mesocephalic and dolicho-
cephalic dogs were mainly found within Gundog and Hound groups, respectively. The distribution of MRI scans 
across craniofacial categories according to genetic clade64 (Supplementary Fig. S5) identified a large contribution 
of European Mastiff, Retriever, and UK Rural clades to brachycephalic, mesocephalic, and dolichocephalic MRI 
scans, respectively. Overall, our cohort reflected the complex demographic of canines referred to neurology, on a 
background of current breed preferences among UK dog owners.
4Scientific RepoRtS |         (2019) 9:12506  | https://doi.org/10.1038/s41598-019-48446-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
C
ra
ni
of
ac
ia
l r
at
io
Brachycephalic
Mesocephalic
Dolichocephalic
298 MRI scans 
286 MRI scans 
12 excluded 
9,438 data points 6,864 data points 
2,574 data points 
Age category Dogs Scans
Immature 36 37 
Young adult 32 32 
Middle-aged 105 107 
Mature 55 56 
Geriatric 53 54 
Sex Dogs Scans
FE 43 44
FN 90 92
ME 53 53
MN 95 97 
Clinical data 
24 morphometric 
parameters 
0 t
o 5
5 t
o 1
0
10
 to
 15
15
 to
 20
20
 to
 25
25
 to
 30
30
 to
 35 35
 +
0
5
10
15
20
Body weight (kg)
Pe
rc
en
ta
ge
 o
f M
R
I s
ca
ns
 (%
)
Crossbreed
Gundog
Hound
Pastoral
Terrier
Toy
Utility
Working
53 x 48 mm 77 x 49 mm 85 x 59 mm 88 x 54 mm 
Afghan hound 
(dolichocephalic) 
Labrador Retriever 
(mesocephalic) 
Boxer 
(brachycephalic) 
Chihuahua 
(brachycephalic) 
Breed MRI 
scans 
Breed MRI 
scans 
Breed MRI 
scans 
BOX 18 BEAG or BEAG X 6 GSD 6 
CKCS 25 BORD 13 DANE 1 
CHIH 7 BORT 6 GREY 5 
FBUL 10 CROS 7 WEIM 6 
PUG 9 ECKR 12 WHIP 5 
SBT or SBT X 10 ESSP 8 TOTAL          39 
TOTAL               102 GOLD 7 
JACK 9 
LAB 37 
WHWT 7 
TOTAL                    145 
a b
e f
c
4 6 8 10
4
6
8
10
12
14
16
Brain length (cm)
C
ra
ni
al
 le
ng
th
 (c
m
)
Brachycephalic
Mesocephalic
Dolichocephalic
d
Slope ± SEM R2 
1.87 ± 0.07 0.870
1.63 ± 0.07 0.806
1.32 ± 0.16 0.647
**** 
*** 
**** 
0.0
0.2
0.4
0.6
0.8
1.0
Figure 1. A diverse and complex canine neurological cohort. (a) Canine brain MRI scans; 12 were excluded 
due to lack of required MRI sequences; of the remaining 286 scans, 255 were from pure-bred dogs. Numbers 
of individual patients and MRI scans included in network analysis are tabulated. Five patients underwent 
two scans on separate dates. (b) Percentage of MRI scans by body weight according to breed group. (c) 
Measurable CFRs (screened from 333 MRI scans). Difference between group means was significant (N = 134; 
P < 0.0001; one-way ANOVA; horizontal bars represent mean values and asterisks refer to multiplicity 
adjusted P-values by Tukey’s method ****P < 0.0001 ***P = 0.0007). (d) Linear regression of cranial length 
versus brain length according to craniofacial category. Differences between slopes were significant (P = 0.01 
brachycephalic versus mesocephalic, P = 0.0007 brachycephalic versus dolichocephalic, P = 0.04 mesocephalic 
versus dolichocephalic); SEM = standard error of the mean. (e) Computed brain volumes for representative 
dolichocephalic, mesocephalic, and both large and small brachycephalic breeds; mean brain lengths and 
widths are shown for each breed. (f) Numbers of MRI scans used in network analysis for breeds with ≥ five 
representatives, by craniofacial category (brachycephalic, yellow; mesocephalic, grey; dolichocephalic, green). 
BOX (Boxer), CHIH (Chihuahua), FBUL (French Bulldog), PUG (PugDog), SBT (Staffordshire Bull Terrier), 
BEAG (Beagle), BORD (Border Collie), BORT (Border Terrier), CROS (Crossbreed), ECKR (English Cocker 
Spaniel), ESSP (English Springer Spaniel), GOLD (Golden Retriever), JACK (Jack Russell Terrier), LAB 
(Labrador Retriever), WHWT (West Highland White Terrier), GSD (German Shepherd Dog), DANE (Great 
Dane), GREY (Greyhound), WEIM (Weimeraner), WHIP (Whippet). Canine breed image attributions: 
AFGH (By SheltieBoy (Flickr: AKC Helena Fall Dog Show 2011) [CC BY 2.0 (https://creativecommons.org/
licenses/by/2.0)]); BOX (By Flickr user boxercab (Flickr here) [CC BY 2.0 (https://creativecommons.org/
licenses/by/2.0)]); CHIH (Photo taken by en:User:Exdumpling in 2004 and uploaded to English Wikipedia 
as WhiteTanChihuahua.jpg claiming own work with PD-self license); LAB (By Desaix83, d’après le travail de 
Chrizwheatley [Public domain]).
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Network analysis reveals clustering of canine brains. At a correlation threshold of r = 0.7, a graph 
was generated incorporating 273 MRI scans (nodes) and 3,911 correlations (edges) (Figs 2a, S6, Supplementary 
Data File S3). The graph’s topology exhibited distinct cliques (areas of high connectivity) and with MCL pro-
duced 12 clusters, incorporating 250 scans (Supplementary Fig. S7, Supplementary Table S1). Patients within 
each cluster shared similar brain morphometric features, with 71.3% of scans residing in one of six large clus-
ters (Fig. 2b). Figure 2c–e compare the brain morphometry profiles of the three most common breeds within 
the network; CKCS dogs were distinguished by their ventricular parameters and cerebellar compression, and 
Boxer and Labrador brains diverged mainly on the basis of ventricular size. To evaluate the statistical signifi-
cance of cluster composition, an enrichment analysis was performed for each cluster of data (Fig. 2f). Cluster 
one was enriched for brachycephalic Working dogs (including 14 Boxers). Immature and Chihuahua dogs were 
over-represented in cluster two, whilst cluster three was enriched for mesocephalic Gundogs including Labradors. 
Cluster four featured mesocephalic Crossbreed dogs, and mesocephalic dogs were also over-represented in cluster 
five. Dolichocephalic and geriatric dogs were enriched in clusters eight and eleven, respectively. Overall, relative 
to other craniofacial categories, brachycephalic dogs had larger brain widths, enlarged ventricular parameters, 
and greater cerebellar compression (Figs 3a,b, S8). Conversely, dolichocephalic dogs had narrower brains with 
intermediate ventricular volumes, and mesocephalic dogs had small ventricular volumes. Variation was observed 
in brain morphometry profiles according to sex; un-neutered animals had larger brains relative to their body 
weight, although this was offset by an increased ventricular size and sulcus depth in males (Fig. 3c,d). Neutered 
and un-neutered females had the largest and smallest ventricular volumes, respectively. Whole brain parameters 
(length, width and volume), ventricular size, sulcus depth, and corpus callosum thickness separated the youngest 
and oldest dogs (Fig. 3e–f). In summary, signalment (breed, craniofacial category, sex, and age) appeared to drive 
the clustering of canine brains, with ventricular size and brain width being most impacted by these factors.
Clinical-morphometric interactions identify the Boxer as an outlier. Observing that some diag-
nostic classes were prominent among certain demographic categories and clusters (Fig. 3g, Supplementary 
Figs S9–10), we next explored correlations between signalment, brain morphometry, and neurological disease. 
Interestingly, cluster one contained 26 dogs with tumour diagnoses (ten of which were Boxers) and there were 
patients in all breed groups with ‘idiopathic’ diagnoses based on clinical signs and a normal MRI—many of 
these had epilepsy. The Fisher’s exact test was used to detect enrichment of signalment descriptors within each 
diagnostic class (Fig. 3h). Significant enrichments included brachycephalic dogs within the anomalous class, 
whilst geriatric dogs were enriched within tumour and vascular classes. Four out of ten Pointer Setter dogs had 
brain tumours, and three of these were neutered female geriatric Weimeraners (age and breed co-enriched with 
adjusted P-value of 2.38 × 10−2). Boxer dogs were greatly enriched within the tumour class, and mesocephalic 
dogs were over-represented within the idiopathic class. With respect to breed group, the anomalous class was 
significantly enriched for Toy dogs (mainly CKCS reflecting the high prevalence of Chiari-like malformation in 
this breed)65, whilst the tumour class was enriched for Working group dogs (mainly Boxers). Again, ventricular 
size strongly dictated clustering and group dynamics; four out of seven Labrador Retrievers positioned in cluster 
one had tumours and large ventricular parameters. Working and Toy breeds had the largest ventricular volumes, 
but these breed groups dramatically diverged with respect to whole brain parameters and sulcus depth. Strikingly, 
Boxers had remarkably narrow brains (Fig. 4a), accentuating a feature more consistent with a dolichocephalic 
phenotype (Fig. 3a). Moderate to severe loss of the septum pellucidum (membrane that separates the lateral ven-
tricles of the brain) was prominent in the European Mastiff clade, which was also enriched for entire male dogs 
(adjusted P-value 9.55 × 10−3). Septal integrity was most compromised in the Boxer; only five out of 18 dogs had 
a visually intact septum (Supplementary Fig. S11). Combined with ventriculomegaly, the reduced whole brain 
dimensions in the Boxer resulted in a small residual brain tissue volume relative to body size, a feature which 
clearly separated the Boxer from other brachycephalic breeds (Fig. 4b). Together, our results defined the Boxer 
as an outlier, displaying both brachycephalic and dolichocephalic morphometric features, alongside an increased 
tumour risk.
Advanced ‘brain age’ in the Boxer and neutered female dogs. Having confirmed enrichment of the 
Boxer breed with tumours, but not with the geriatric class (despite geriatric scans being enriched for tumours), 
we considered that Boxer brains may be subject to accelerated ageing. Indeed, Boxer brain morphometry profiles 
exaggerated those of mature and geriatric dogs (Fig. 3e). Apart from ventriculomegaly, the ‘aged’ Boxer profile did 
not broadly represent the brachycephalic phenotype (Fig. 4c,d). Boxer brain morphometric features were shared 
with some other members of the Working group (Rottweiler and Dogue de Bordeaux), and European Mastiff 
clade (Boston Terrier and Rhodesian Ridgeback; Supplementary Fig. S12), but not all representatives (French 
Bulldog and Staffordshire Bull Terrier). To confirm that Boxer brain morphometry did not simply reflect tumour 
growth, the profiles of breeds with a high risk of tumours in our cohort (Boxer and Weimeraner) were com-
pared, in the presence and absence of tumour diagnoses (Fig. 4e). In the Boxer, tumour diagnosis was associated 
with a marginal increase in ventricular size, whereas in the Weimeraner, it converted a small ventricular profile 
to one consistent with ventriculomegaly. Follow-up scans in five dogs exposed the dynamism of cerebrospinal 
fluid (CSF)-filled spaces in response to partial or complete resolution of brain lesions (Supplementary Fig. S13). 
However, the ‘aged’ morphometry profile appeared unique to the Boxer and was retained both before and after 
treatment. Intriguingly, the aged Boxer profile mimicked that of neutered females (Fig. 4f), which had a high 
proportion of tumour diagnoses (21.1%) relative to un-neutered females (4.6%; the lowest percentage of the 
four sex categories within the network). By contrast, un-neutered females had large whole brain parameters and 
small ventricles (P = 0.004, unpaired two-tailed t-test with Welch’s correction, relative to neutered females), and 
enriched with immature brain profiles (P = 8.97 × 10−4; Supplementary Fig. S14). Critically, although neutered 
females were on average older than un-neutered females in our cohort, the relative increase in the size of their 
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Figure 2. Network analysis reveals clustering of canine brains based on morphometry. In the network, nodes 
represent individual MRI scans; edges represent Pearson correlation coefficients (r > 0.7) between their brain 
morphometry profiles. Non-clustered and unselected nodes are displayed as smaller transparent spheres. Some 
nodes are hidden within clusters or on other aspects of the graph; iterations of the network can be explored by 
inputting Supplementary Data File S3 into Graphia Professional. (a) Network with nodes coloured by cluster; 
median lines for the six largest clusters are shown in associated chart (b). Note that sulcus depth, ventricular 
volume, and whole brain parameters (length, width, volume) drive divergence of canine brain morphometry 
profiles. (c–e) Brain morphometry comparison for three most common breeds in the cohort. Arrows in 
(d) indicate key morphometric parameters tested in (e) (N = 79). Differences between group means were 
significant as shown in the inset table (one-way ANOVA); in the dot plots, horizontal bars represent the mean 
value and asterisks refer to multiplicity adjusted P-values by Tukey’s method (****P < 0.0001, ***P < 0.001). 
(f) Enrichment analysis of breeds, craniofacial categories and age categories within clusters. Enrichments are 
listed only where observed node numbers were ≥ three (minimum cluster size). Note strong enrichment of 
brachycephalic Boxer dogs in cluster one. Canine breed image attributions: BOX (By Flickr user boxercab 
(Flickr here) [CC BY 2.0 (https://creativecommons.org/licenses/by/2.0)]); CKCS (By Mário Simoes (Flickr: 
Cavalier King Charles Spaniel) [CC BY 2.0 (https://creativecommons.org/licenses/by/2.0)]); LAB (By Desaix83, 
d’après le travail de Chrizwheatley [Public domain]).
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ventricles was significant in the geriatric group (Supplementary Fig. S15). Within the network, seven of ten Boxer 
dogs with tumours were middle-aged. Prospective analysis of 148 dogs presenting for brain MRI at our institution 
identified an additional 23 dogs with brain tumours, all of which were entire males or neutered animals, including 
four Boxers with a mean age of 7.5 y. Boxers and other brachycephalic dogs were thus diagnosed earlier with brain 
tumours than other breed types (Fig. 4g). Finally, considering all brain scans performed to date (441 in 429 dogs), 
and excluding tumours that had metastasized from other parts of the body to the brain (Supplementary Data 
File S4), neutering increased the relative risk of brain tumours 11-fold in females (odds ratio 13.5, P = 0.0006, 
95% confidence interval 2.4-141.4), and un-neutered females were seven times less likely to suffer brain tumours 
than un-neutered males (odds ratio 7.5, P = 0.03, 95% confidence interval 1.3-82.4). In conclusion, our findings 
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Figure 3. Signalment and diagnosis impact on canine brain morphometry. Brain morphometry comparisons 
by (a,b) craniofacial category, (c,d) sex, and (e,f) age category. Arrows in (a,c,e) indicate key morphometric 
parameters tested in (b) (N = 286), (d) (N = 286), and (f) (N = 179) by one-way ANOVA or Kruskal-Wallis 
(K-W) test as required. Differences between group means or medians (horizontal bars) are shown in each inset 
table, with significance depicted in shaded boxes; asterisks refer to multiplicity adjusted P-values by Tukey’s or 
Dunn’s method (****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05). In (c) and (d) FE = un-neutered females, 
FN = neutered females, ME = un-neutered males, and MN = neutered males. (g) Heat maps and chart coloured 
by final neurological diagnosis. Note enrichment of tumour diagnoses with both the geriatric group and Boxer 
breed. Network graphs for each diagnostic class are visualized separately in Supplementary Figure S10. (h) 
Enrichment analysis results for diagnostic class sets. Table lists significant enrichments together with expected 
and observed numbers for each descriptor that occurred in a given class, with adjusted P-values. Enrichments 
were excluded where observed number of nodes was < three (minimum cluster size). For each class, descriptors 
are listed in order of statistical significance. No enrichments were found within diagnostic class sets for septal 
integrity or sex.
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Figure 4. Advanced ‘brain age’ linked to tumour risk and oestrogen loss. (a) Linear regression of total brain volume 
versus brain width; differences between Boxer and other slopes were significant (P = 0.004 other brachycephalic, 
P = 0.0001 mesocephalic, P = 0.02 dolichocephalic); SEM = standard error of the mean. (b) Residual brain tissue 
volume (ventricular volume subtracted from total brain volume) normalized to body weight. Difference between 
group medians (horizontal bars) was significant (N = 286, P < 0.0001; Kruskal-Wallis); asterisks refer to multiplicity 
adjusted P-values by Dunn’s method (****P < 0.0001). (c,d) Total brain volume, brain width, and sulcus depth 
(arrowed) appear small in the Boxer relative to other brachycephalic breeds; horizontal bars in (c) represent median 
values and asterisks refer to statistical significance Mann-Whitney test (N = 72, ****P < 0.0001). Note that statistical 
comparisons with the brachycephalic group are not made since, in this instance, Boxers (and also some Toy breeds) 
are included within the brachycephalic group. (e) The Boxer brain morphometry profile is not explained by tumour 
growth, which in another large breed (Weimeraner) has a marked impact on ventricular size and network position 
(Supplementary Fig. S13g). (f) Brain morphometry of neutered female dogs mimics that of mature and geriatric dogs, 
with a significantly larger ventricular volume than in un-neutered females (N = 136, P = 0.004; unpaired two-tailed 
t-test with Welch’s correction). (g) Age distribution of patients diagnosed with brain tumours since the start of the 
study period by craniofacial category. Difference between group means (horizontal bars) was significant (N = 67, 
P < 0.0001; one-way ANOVA); asterisks refer to multiplicity adjusted P-values by Tukey’s method (**P < 0.01, 
*P < 0.05). (h) Proposed model for factors contributing to advanced brain age and brain tumour risk in dogs. 
Photograph of canine brain contributed by lead author.
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suggest that oestrogen may be protective against brain ageing and brain tumour growth in dogs, whereas the 
Boxer is at high risk for both (Fig. 4h).
Discussion
Applying a data-driven approach, we have identified an aged-brain morphometric phenotype in Boxers and neu-
tered female dogs that enriches with brain tumour risk. To our knowledge, this is the first network analysis of 
global brain morphometry, and the first study to link brain tumour risk to structural brain ageing. Our results are 
consistent with the hypothesis that structural ‘brain age’ influences disease risk, and that oestrogen plays a role in 
brain ageing and tumour growth.
All canine patients underwent MRI because of brain-localising signs, therefore our cohort does not represent 
healthy brain ageing. Combining idiopathic and normal (undiagnosed) patients, our network included 31.3% 
structurally ‘normal’ brains. Subtle morphometric changes (Supplementary Fig. S16) caution against describing 
idiopathic epileptic brains as ‘normal’66, although others have used epileptic patients to establish reference values 
in dogs34. Some tumour diagnoses were not confirmed because a necropsy was not performed (Supplementary 
Data File S4), although other major differentials were ruled out with CSF analysis. Manual planimetry techniques 
are arguably more precise than semi-automated approaches42, and the measurement protocol used for this study 
had a similar time commitment to that reported with atlas-based segmentation (around 30 min per brain)44. 
However, given the time and effort required by trained clinical staff to extract the data, we do not advocate the 
use of this protocol for routine clinical application; rather we highlight the value of applying network analysis 
to complex clinical datasets. Whilst templates derived from a small number of breeds without structural brain 
pathology enable reproducible morphometric analysis29,44,45,67, these templates rapidly become inaccurate in the 
face of structural brain disease44. Milne et al., attempted to account for craniofacial diversity in their development 
of brain atlas templates, however the patients used to generate these templates included neurologically abnormal 
dogs (with ataxia, vestibular disease, and idiopathic cerebellitis) and the assignment of craniofacial category was 
subjective44. The authors argue that ‘subjective evaluation allows for the formation of a global opinion by taking 
into account a complex array of volumetric factors and spatial relationships’; by contrast, we have taken objective 
measurements and then used network analysis to extract an unbiased view of the complex relationships between 
them. Importantly, this approach is readily applicable to datasets extracted by manual or automated methods. 
Referral bias will have magnified enrichments for breeds that most frequently present to our institution; network 
analysis partly controls for this issue, but it cannot eliminate the need for larger datasets to model disease risk at 
the population level.
A 40-fold difference in skeletal size exists between the largest and smallest dog breeds, and there is a strong 
correlation between body weight and the volume of several brain compartments34,50,62,68,69. Most parameters were 
normalized to total brain volume to help control for individual and breed variations in brain morphometry25,30,70. 
Some have argued against using ventricular-to-cerebrum ratio to assess brain ageing since such measures would 
be breed-specific62, yet this presumes that ventriculomegaly reflects normal breed variation. Boxers without cere-
bral disease have large lateral ventricles relative to other breeds71, however the definition, development, and clin-
ical significance of ventriculomegaly in dogs remains controversial72. Ageing has been associated with changes in 
brain and ventricular volume in dogs, but most data comes from laboratory Beagles16,18,23,24,26,27,29,30,35,73. Given the 
extensive breed variation in canine ventricular morphology, age- and breed-specific reference ranges (obtained 
from neurologically normal dogs using a standard set of MRI sequences) are needed to determine the relevance 
of our findings to the broader canine population. Training healthy dogs to participate in advanced neuroimaging 
studies without anaesthesia may address some ethical concerns and deliver the statistical power required for 
complex morphometric research questions5,42. Current limitations including the potential impact of brain pathol-
ogy on specific morphometric parameters preclude us from defining a statistical threshold for ventriculomegaly. 
Likewise, we consider it inappropriate to quantitatively define ‘brain age’ from our retrospective dataset; rather we 
refer to an ‘aged-brain profile’, reflecting the specific combination of morphometric parameters that characterize 
this structural brain phenotype in our cohort.
Certain observations built confidence in our analysis, not least the relative ventriculomegaly in brachycephalic 
breeds, and cerebellar compression in CKCS dogs65,72,74. Enrichment of Boxers with tumours was anticipated74 
and the compromised septal integrity in this breed is more common in brachycephalics generally (29% versus 
9% and 13% in mesocephalic and dolichocephalic breeds in our network, respectively). Non-detection of the 
canine septum pellucidum on MRI is largely considered incidental70,75,76, and it remains possible that the septum 
is intact, but too thin to be observed in some dogs70. Apparent absence of the septum has been observed in neuro-
logically normal humans but is often associated with other structural anomalies70,77. Interestingly, 21 of 25 CKCS 
dogs in our cohort had intact septa, despite their high prevalence of Chiari-like malformation78. Conceptually, 
a compromised septum might increase ventricular compliance and thus explain why Boxers are at low risk of 
Chiari-like malformation and syringomyelia, despite shared ventricular morphology with CKCSs.
The need to explore sexual dimorphism in brain ageing is underpinned by the fact that dementia dispropor-
tionately affects women79. The largest ever single-sample neuroanatomical study of sex differences using UK 
Biobank data found several sexually dimorphic differences in human brain structure42. Importantly these changes 
operated in a global manner, supporting our approach to consider multiple morphometric features in concert, 
and to correct for total brain volume. Age-related structural brain changes differ between men and women36, and 
also between male and female dogs16,29. Men exhibit greater increases in sulcal and ventricular CSF volume36,37, 
whilst women demonstrate greater rates of hippocampal atrophy38–40. A semi-quantitative visual rating scale was 
used to chart cerebral involutional changes in dogs, however neither sex nor neutering status were considered 
as co-variates23. One canine study reported that different brain regions appeared more vulnerable to atrophy in 
males—although these animals were all sexually intact29. Post-mortem studies in German Shepherd Dogs found 
ventricular enlargement with ageing and no apparent relationship to sex, although again the effect of neutering 
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was not explored27. By contrast, our results indicate an accelerated ventriculomegaly and total brain loss in neu-
tered female dogs. Importantly, whilst there was a difference in age distribution between sex categories in our net-
work, there was a trend for enhanced ventriculomegaly in neutered females across all age categories in adulthood, 
reaching significance in the geriatric group. To the authors’ knowledge, this is the first study to demonstrate an 
effect of neutering status on brain morphometry in dogs.
Oestrogen deficiency is proposed to explain accelerated brain ageing in post-menopausal women as 
well as an accelerated epigenetic clock in ovariectomized mice80–82. Several meta-analyses have shown 
hormone-replacement therapy (HRT) to be neuroprotective, and although recent publications have raised doubt 
over the ‘oestrogen deficiency’ theory of dementia83–85, HRT may still defend cognition in a subgroup of women in 
the perimenopausal period85,86. Our work supports the concept that oestrogen loss may accelerate neural decline, 
however causal mechanistic insight is lacking. Development of multicentre canine biobanks will facilitate investi-
gations of oestrogen status as a function of brain ageing in dogs, and whether this relates to cognitive dysfunction. 
In human patients, advanced structural ‘brain-age’ is often paralleled by epigenetic markers of ageing9,11,87,88. The 
premise that oestrogen may have neuroprotective benefits across the lifespan—and that its effects may be epige-
netically regulated89—emphasises the need to integrate structural, functional, and molecular approaches in the 
study of brain ageing and brain disease.
Canine gliomas occur most commonly in brachycephalic breeds, with the Boxer at highest risk74. We noted 
a significant enrichment of brain tumours with Boxers, however the absence of tumour diagnoses in CKCS dogs 
resulted in non-enrichment of tumours within our brachycephalic category. The majority of Boxers in our cohort 
were middle-aged, consistent with the findings of Song et al. where gliomas most frequently occurred in dogs 
aged seven-to-eight years74. This is despite the fact that increasing age remained a risk factor for all intracranial 
neoplasias (as seen here)74. An increased risk of primary intracranial neoplasms has also been found in large 
breed dogs74, and indeed, only 11 of 52 dogs with tumour diagnoses in our network were small breeds. Most size 
variation between purebred dogs is controlled by a few genes of major effect, including several members of the 
insulin-like growth factor-1 (Igf-1) pathway4,46,50. Igf-1 is a major determinant of dog size; its variable expression 
is proposed to underlie the increased longevity of smaller breeds and the higher frequency of neoplasia-associated 
deaths in large breeds62. Coincidentally, the rapid growth of large breeds may initiate premature ageing due to 
increased free radical release during development90. Roughly half of small or medium breed dogs also have ‘large 
alleles’, mainly found in muscled breeds such as the French Bulldog and Boxer46,48. Our analysis reveals that 
Boxers have ventricular parameters of the small brachycephalic phenotype, but whole brain parameters of large 
breed mesocephalic or dolichocephalic phenotypes. Conceivably, a combination of variants promoting brachy-
cephaly (e.g. Smoc2), on a background of those promoting growth (Igf-1) may place the Boxer at extreme risk of 
premature ageing and brain tumours48.
Although primary brain tumours can affect men or women at any age, emerging evidence supports a role 
for both chromosomal and gonadal sex in neuro-oncogenesis and brain ageing91. Malignant gliomas are more 
common in men globally, and the risk of intracranial tumours is increased in women with complete or partial 
X-chromosome monosomy and low oestrogen levels92–94. The human male predominance for brain tumours 
appears to persist in all age groups, indicating that acute effects of circulating sex steroids cannot simply explain 
the sexual disparity in tumour risk92. Mosaic loss of chromosome Y, the most common acquired human mutation 
and another putative biomarker of ageing, has been associated with an increased risk both of Alzheimer’s disease 
and various cancers95–97. To our knowledge, this is the first study to report a reduced risk of brain tumours in 
un-neutered female dogs relative to neutered animals. Given the routine (but not mandatory) practice of neuter-
ing, an unrivalled opportunity exists to explore the influence of chromosomal and gonadal sex on neuropathology 
in canines of varied neutering status.
Extreme breed characteristics impact on health and welfare, with widespread concerns surrounding brach-
ycephaly61,90. Our work extends this to the brain, highlighting an urgency to better understand the factors that 
influence brain ageing in dogs. Simultaneously, comparative studies will accelerate our knowledge of how chro-
mosomal and hormonal sex affect brain structure, brain ageing, and brain tumour development in humans. The 
Boxer breed in particular could represent a valuable model of naturally-enhanced brain ageing. Larger, longitudi-
nal imaging studies are required to confirm how patient demographics influence brain age—network analysis can 
facilitate discovery of subtle yet important phenotypic shifts within these complex clinical datasets. Importantly, 
our unique application of network analysis can be immediately translated to pre-existing and emerging human 
patient data. A key question is whether canine brain morphometry and associated morbidity can be explained by 
selectively-driven changes in skull shape, or whether independent genetic, epigenetic, or epidemiological factors 
contribute to neurological disease. Isolating these factors will advance our understanding of disease pathogenesis, 
with important implications for canine and human brain health3,6.
Data Availability
Anonymised DICOM files are available on request. Supplementary Data Files are deposited at Mendeley Data 
(https://doi.org/10.17632/y2f9272bbd.1). Graphia Professional is free to download at https://kajeka.com/graph-
ia-professional/.
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